|
Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History (PATH) |
1K23AG075261-01A1 |
|
NIA |
2022 |
|
Administration Core |
1P01AG073090-01A1 |
|
NIA |
2022 |
|
Parenchymal border macrophages in AD and CAA |
1P01AG078106-01 |
|
NIA |
2022 |
|
Interplay between meningeal lymphatics, high-density lipoproteins and border macrophages in cerebral amyloid angiopathy |
1P01AG078106-01 |
|
NIA |
2022 |
|
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics |
1P01AG078106-01 |
|
NIA |
2022 |
|
Project 3 - Astrocytic glutamate dysregulation in AD and VCID |
1P01AG078116-01 |
|
NIA |
2022 |
|
Project 2 - Astrocytic insulin signaling and AD |
1P01AG078116-01 |
|
NIA |
2022 |
|
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA. |
1R01AG074983-01 |
|
NIA |
2022 |
|
Preoperative perturbation training to prevent falls after total knee arthroplasty |
1R01AG075098-01A1 |
|
NIA |
2022 |
|
Predicting Functional Decline and Clinical Outcomes in Newly Diagnosed Older Patients with Localized Bladder Cancer |
1R03AG073990-01A1 |
|
NIA |
2022 |